Browse studies
Find your next paid study
5 recruiting studies matching your filters
Phase 2
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)
Researchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffness, and i…
Radiographic Axial Spondyloarthritis
Estimated
~$10 – $8,750
Merck Sharp & Dohme LLCNCT07133633
Phase 1
An Open-label, Randomized, Parallel-group, Noninferiority Study to Evaluate the Pharmacokinetics of Bimekizumab Administered Intravenously or as a Subcutaneous Injection in Participants With Active Psoriatic Arthritis and/or Active Axial Spondyloarthritis
To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.
Psoriatic ArthritisAxial Spondyloarthritis
Estimated
~$10 – $8,750
UCB Biopharma SRLNCT07290036
Observational
Expanding Access to Early Exercise Prescriptions for Underserved Patients With Axial Spondyloarthritis: A Digital Health Approach
The purpose of this study is to find out whether a mobile app called the ExerciseRx app is a practical and helpful way for people with axial spondyloarthritis …
Axial Spondyloarthritis
Estimated
~$10 – $6,250
University of WashingtonNCT07642622
Phase 1
A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more
Estimated
~$10 – $8,750
UCB Biopharma SRLNCT06888193
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
The most clinically meaningful way to discover new targets of T cells in autoimmune diseases is to study the tissues of patients with active autoimmune disease…
Autoimmune DiseasesUlcerative ColitisMultiple Sclerosis+6 more
Estimated
~$10 – $1,050
TScan Therapeutics, Inc.NCT06587828